Abbott Laboratories (ABT)

R&D Expenses

$882.00M

Quarterly · Period ending: · USD

ABT logo

ABT R&D Expenses

Latest reported$882.00M
ABT Quarterly R&D Expenses ($0.00 → $882.00M)
High-resolution chart · PNG

ABT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
882,000,000
756,000,000
735,000,000
785,000,000
732,000,000
703,000,000
728,000,000
713,000,000
697,000,000
683,000,000
690,000,000
661,000,000
710,000,000
654,000,000
691,000,000
780,000,000
684,000,000
697,000,000
758,000,000
672,000,000
654,000,000
654,000,000
698,000,000
580,000,000
564,000,000
576,000,000
575,000,000
594,000,000
577,000,000
670,000,000
561,000,000
573,000,000
573,000,000
581,000,000
618,000,000
493,000,000
520,000,000
541,000,000
338,000,000
336,000,000
348,000,000
379,000,000
369,000,000
378,000,000
345,000,000
313,000,000
361,000,000
307,000,000
335,000,000
387,000,000
386,000,000
357,000,000
363,000,000
346,000,000
1,141,431,000
1,164,000,000
1,011,000,000
1,006,000,000
1,151,607,000
1,010,000,000
1,038,000,000
930,000,000
1,295,632,000
1,079,000,000
858,000,000
730,000,000
747,048,000
676,000,000
670,000,000
650,743,000
731,631,000
680,360,000
656,863,000
619,957,000
662,401,000
640,718,000
583,474,000
578,374,000
596,167,000
617,625,000
1,049,337,000
485,142,000
490,392,000
448,869,000
445,258,000
436,656,000
463,967,000
391,698,000
436,510,000
429,024,000
485,693,000
438,999,000
402,753,000
406,027,000
432,494,000
393,125,000
379,492,000
356,681,000
461,365,000
400,566,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.